Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.69B | $6.32B | +5.88% |
Operating Income | $1.82B | $1.96B | -7.24% |
Net Income | $1.43B | $968.4M | +47.90% |
EPS (Basic) | $19.95 | $16.69 | +19.53% |
EPS (Diluted) | $18.68 | $15.68 | +19.13% |
R&D Expense | $2.45B | $2.19B | +11.98% |
SG&A Expense | $1.45B | $1.25B | +15.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $36.09B | $30.66B | +17.71% |
Current Assets | $19.08B | $16.92B | +12.76% |
Total Liabilities | $7.88B | $6.64B | +18.70% |
Current Liabilities | $3.51B | $3.1B | +13.02% |
Stockholders' Equity | $28.21B | $24.02B | +17.44% |
Cash & Equivalents | $1.92B | $1.94B | -0.85% |
Long-Term Debt | $1.98B | $1.98B | +0.07% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.87B | $2.39B | -21.90% |
Investing Cash Flow | $-2.24B | $-2.62B | +14.42% |
Financing Cash Flow | $-431M | $-936.7M | +53.99% |
Dividends Paid | $0 | — | — |
Share Buybacks | $895.2M | $1.4B | -36.03% |
D&A | $234.8M | $202.6M | +15.89% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 27.2% | 31.1% | -3.85% |
Net Margin | 21.4% | — | — |
ROE | 5.1% | — | — |
ROA | 4.0% | — | — |
Current Ratio | $5.439 | — | — |
Debt to Equity | $0.279 | — | — |
Other companies in Biotechnology